IRVING, Texas, Dec. 13 /PRNewswire-FirstCall/ -- Allarae Healthcare, Inc. (Pink Sheets: ALHI) announced today that it has signed a Distribution Agreement with Intellect, Inc. to sell their entire product line on a non-exclusive basis, worldwide. Intellect, Inc. has developed a broad range of personal health testing kits, several already FDA approved, and personal tracking software for home use. The test kits are ready for market but have not yet been commercialized.
The Company further stated that tests for strep, influenza, cholesterol, and glucose levels are the first to be packaged for immediate sale. Tests for certain other conditions including certain forms of cancer and hepatitis are near completion and will be ready for the market in 2008.
Allarae's President, Phil Matteis, stated that the Company's goal is to become the premier provider of personal health management products. The vision for the company is to provide a complete toolkit that will allow the individual to manage their health more effectively.
This is the second licensing agreement to be signed by the Company. In November of this year a License Agreement was signed with Intellect Holdings, Ltd. for rights to sell its related products and software technology.
"These personal test kits and the related tracking software for individual use are the start of a new era in personal health management and tracking," stated Phil Matteis, President of Allarae. "It will give individuals more control over the management of their own health by giving them the ability to test for numerous disease indicators and track the results on an ongoing basis with their care providers."
The Company stated that additional product announcements will be forthcoming as other products are ready for distribution.
Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks, and uncertainties and actual results could differ from those discussed. This material is information only and is not an offer or solicitation to buy or sell the securities.
CONTACT: Allarae Healthcare, Inc.
Phillip Matteis
972-868-9101
Allarae Healthcare, Inc.
